메뉴 건너뛰기




Volumn 14, Issue 8, 2008, Pages 1259-1262

Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain

(63)  Oteo, Jesús al   Campos, José al,am,ao   Lázaro, Edurne an   Cuevas, Óscar am   García Cobos, Silvia am   Pérez Vázquez, María am   De Abajo, F J an   Loza, E a   Baquero, F a   Fontanals, D b   Berdonces, P c   Moreno, R d   Lopez P e   Royo, G e   Lite, J f   Garau, J f   Megias Lobon G g   Ojeda, E g   Miranda, C h   Rojo, M D h   more..


Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PENICILLIN G;

EID: 48849112024     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1408.071059     Document Type: Article
Times cited : (44)

References (11)
  • 1
    • 16244415869 scopus 로고    scopus 로고
    • Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain
    • Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J; Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis. 2005;11:546-53.
    • (2005) Emerg Infect Dis , vol.11 , pp. 546-553
    • Oteo, J.1    Lázaro, E.2    de Abajo, F.J.3    Baquero, F.4    Campos, J.5
  • 2
    • 0034075360 scopus 로고    scopus 로고
    • Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997-1998
    • DOI: 10.1086/313710
    • Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997-1998. Clin Infect Dis. 2000;30:454-60. DOI: 10.1086/313710
    • (2000) Clin Infect Dis , vol.30 , pp. 454-460
    • Fluit, A.C.1    Jones, M.E.2    Schmitz, F.J.3    Acar, J.4    Gupta, R.5    Verhoef, J.6
  • 3
    • 0034777405 scopus 로고    scopus 로고
    • Four-year prospective evaluation of community-acquired bacteremia: Epidemiology, microbiology and patient outcome
    • DOI: 10.1016/S0732-8893-(01)00284-X
    • Lark RL, Saint S, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJ. Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology and patient outcome. Diagn Microbiol Infect Dis. 2001;41:15-22. DOI: 10.1016/S0732-8893-(01)00284-X
    • (2001) Diagn Microbiol Infect Dis , vol.41 , pp. 15-22
    • Lark, R.L.1    Saint, S.2    Chenoweth, C.3    Zemencuk, J.K.4    Lipsky, B.A.5    Plorde, J.J.6
  • 4
    • 13844254907 scopus 로고    scopus 로고
    • ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study
    • Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
    • (2005) Lancet , vol.365 , pp. 579-587
    • Goossens, H.1    Ferech, M.2    Vander Stichele, R.3    Elseviers, M.4
  • 5
    • 0038409785 scopus 로고    scopus 로고
    • Evolución del consumo de antibióticos en España, 1985-2000.
    • Lázaro BE, Madurga SM, de Abajo FJ. Evolución del consumo de antibióticos en España, 1985-2000. Med Clin (Barc). 2002;118:561-8.
    • (2002) Med Clin (Barc) , vol.118 , pp. 561-568
    • Lázaro, B.E.1    Madurga, S.M.2    de Abajo, F.J.3
  • 6
    • 34548138984 scopus 로고    scopus 로고
    • Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data
    • DOI: 10.1093/jac/dkm248
    • Campos J, Ferech M, Lázaro E, de Abajo F, Oteo J, Stephens P, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother. 2007;60:698-701. DOI: 10.1093/jac/dkm248
    • (2007) J Antimicrob Chemother , vol.60 , pp. 698-701
    • Campos, J.1    Ferech, M.2    Lázaro, E.3    de Abajo, F.4    Oteo, J.5    Stephens, P.6
  • 7
    • 48849116706 scopus 로고    scopus 로고
    • cited 2007 Jan 8, Available from
    • European Antimicrobial Resistance Surveillance System [cited 2007 Jan 8]. Available from http://www.rivm.nl/earss
  • 8
    • 48849115370 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute (CLSI, Wayne PA, The Institute;, cited 2008 Jun 27, Available from
    • Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing - 17th informational supplement. M100-S17. Vol 27, No. 1. Wayne (PA): The Institute; 2007 [cited 2008 Jun 27]. Available from http://www.clsi.org
    • (2007) Performance standards for antimicrobial susceptibility testing - 17th informational , vol.27 , Issue.1 SUPPL.EMENT. M100-S17
  • 9
    • 0004100812 scopus 로고    scopus 로고
    • World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo Norway, The Organization;
    • World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo (Norway): The Organization; 2005.
    • (2005) Guidelines for ATC classification and DDD assignment
  • 10
    • 0036174641 scopus 로고    scopus 로고
    • Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection
    • DOI: 10.1093/jac/49.2.367
    • Leflon-Guibout V, Ternat G, Heym B, Nicolas-Chanoine MH. Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection. J Antimicrob Chemother. 2002;49:367-71. DOI: 10.1093/jac/49.2.367
    • (2002) J Antimicrob Chemother , vol.49 , pp. 367-371
    • Leflon-Guibout, V.1    Ternat, G.2    Heym, B.3    Nicolas-Chanoine, M.H.4
  • 11
    • 0036896627 scopus 로고    scopus 로고
    • Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant period
    • DOI: 10.1128/AAC.46.12.3991-3994.2002
    • Miró E, Navarro F, Mirelis B, Sabaté M, Rivera A, Coll P, et al. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant period. Antimicrob Agents Chemother. 2002;46:3991-4. DOI: 10.1128/AAC.46.12.3991-3994.2002
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 3991-3994
    • Miró, E.1    Navarro, F.2    Mirelis, B.3    Sabaté, M.4    Rivera, A.5    Coll, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.